What is CORT's health score?

CORCEPT THERAPEUTICS INC (CORT) has a TradeApes health score of 40 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is CORT's estimated fair value?

Based on our 5-year discounted cash flow model, CORCEPT THERAPEUTICS INC's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is CORT undervalued or overvalued?

Our model currently rates CORT as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for CORT... Refresh in a moment for the full analysis.

CORCEPT THERAPEUTICS INC (CORT)

Healthcare Overvalued low weak

$72.62

Updated: 2026-06-06

TradeApes Score

Financial Strength

35 Weak

Operating Trend

40 Weak

Relative Value

30 Weak

Capital Allocation

40 Weak

Risk

80 Strong

Key Findings

+ Free cash flow positive — business generates real spendable cash

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.